DailyNewsEgypt
Sandoz the global leader in generic and biosimilar medicines, announced the introduction of its 15mg/1.5ml concentration of the OMNITROPE biosimilar growth hormone for the treatment of short stature to the Egyptian market, as part of its ongoing efforts to support Egypt’s Vision 2030. Local healthcare authorities remain committed to addressing various health challenges to enhance […]
The post Sandoz Egypt introduces OMNITROPE 15mg biosimilar growth hormone for the treatment of short stature first appeared on Dailynewsegypt…
Read More
Sandoz Egypt introduces OMNITROPE 15mg biosimilar growth hormone for the treatment of short stature
Daily News Egypt
00:21
Sandoz the global leader in generic and biosimilar medicines, announced the introduction of its 15mg/1.5ml concentration of the OMNITROPE biosimilar growth hormone for the treatment of short stature to the Egyptian market, as part of its ongoing efforts to support Egypt’s Vision 2030. Local healthcare authorities remain committed to addressing various health challenges to enhance
